Literature DB >> 8129660

Correlation of asymmetry of visual field loss with optic disc topography in normal-tension glaucoma.

K Nyman1, G Tomita, C Raitta, M Kawamura.   

Abstract

OBJECTIVE: To compare the differences in optic disc configuration with different stages of visual field loss in normal-tension glaucoma.
DESIGN: Interocular pairwise comparisons.
SETTING: Glaucoma clinic of a teaching hospital. PATIENTS: Thirteen patients with normal-tension glaucoma and asymmetric visual field loss of at least 2.5 dB in the mean defect of the visual field indexes.
INTERVENTIONS: Areas under the optic disc profiles mapped from values for radial sections of the optic disc measured at intervals of 30 degrees and expressed as percentages of the area of a rectangle were obtained from stereophotographs with a computerized image analysis system. Visual fields were tested with automated perimetry (OCTOPUS), using program G1. MAIN OUTCOME MEASURE: Correlation analyses between the interocular differences in the areas under the optic disc profile and the interocular differences in the visual field indexes.
RESULTS: The correlation coefficients between the interocular differences in mean defect and those of the area under the optic disc profile in the superior to temporal sections ranged from -.71 to -.61 (.007 < P < .028). The interocular differences in loss variance correlated with the differences in the area under the optic disc profile in the superior section (r = -.61, P = .0252).
CONCLUSION: The differences in visual field loss between the two eyes in normal-tension glaucoma appear mainly to reflect morphometric changes in the superior half of the optic disc.

Entities:  

Mesh:

Year:  1994        PMID: 8129660     DOI: 10.1001/archopht.1994.01090150079027

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  1 in total

1.  Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric.

Authors:  Cassandra L Schlamp; Yan Li; Joel A Dietz; Katherine T Janssen; Robert W Nickells
Journal:  BMC Neurosci       Date:  2006-10-03       Impact factor: 3.288

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.